United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2514_3ef6e9bd-a57d-4a13-a845-f2dd47f895fe
- Product NDC
- 71335-2514
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190301
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2514-1) · 71335-2514-1
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2514-2) · 71335-2514-2
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2514-3) · 71335-2514-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →